Navigation Links
Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
Date:6/9/2009

PALO ALTO, Calif., June 9 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented this week during the Associated Professional Sleep Societies (APSS) 2009 Annual Meeting in Seattle, Washington and also during the European League Against Rheumatism (EULAR) Congress in Copenhagen, Denmark.

Following are the details on each of these data presentations.

  • At APSS on June 10, 2009, Dr. Todd Swick will be presenting a poster entitled "Impaired Sleep and Daytime Functioning at Baseline in Subjects with Fibromyalgia: a 14-week Randomized, Double-blind, Placebo-controlled Trial of Sodium Oxybate" in the 10:15 am-12:15 pm poster session.
  • At APSS on June 11, 2009 at 9:00 am in Ballroom 6E, Dr. Swick will also deliver an oral presentation entitled "Sodium Oxybate Improves Pain, Fatigue, and Sleep in Fibromyalgia: Results from a 14-week Randomized, Double-blind, Placebo-controlled Study."
  • At EULAR on June 12, 2009, in Room C2 from 5:30-7:00 pm, Dr. I. Jon Russell will be presenting "Sodium Oxybate in the Treatment of Fibromyalgia" at a UCB-sponsored Symposium entitled: "Fibromyalgia: How Much More than Pain?" The symposium will be chaired by Dr. Ernest Choy and also features Dr. Gilles Lavigne and Dr. Michael Spaeth as speakers.

Jazz Pharmaceuticals has completed a second Phase III pivotal clinical trial of JZP-6 and expects to announce top-line results from that study in mid-2009. Assuming positive results in the second study, the company anticipates submitting a New Drug Application for sodium oxybate for the treatment of fibromyalgia to the U.S. Food and Drug Administra
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 Prime Pacific ... is excited to announce a new series of ... the industry’s carbon footprint while improving treatment efficacy ... Eco-Flex™, the world’s first waste hose ... game-changer for hydrotherapists,” claims the company’s president, Mr. ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part of its ... applications on the market for iOS, Android, and Windows. Joe Toohey, ... and shared with viewers how this application walks users through recipes. ... good navigator people had to know how to read a map? ... navigator. Well what if people could “GPS” their way through a ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 vcfo, a ... HR, IT and operational support to optimize business performance ... CFOs, Jack Lynch and Michael Scheaffer. Both Lynch and ... and leadership experience. , “We are delighted to ... Wood, vcfo CEO. “Leveraging their background in financial management ...
(Date:5/6/2015)... Healthcare jobs platform, JobMedic.com, has quickly ... The company connects hospitals, home-health, and other medical organizations ... industry. Likewise, job seekers are able to locate jobs ... unique traffic to the site is up more than ... posting brings targeted, interested candidates to the site through ...
(Date:5/6/2015)... The Alliance for Regenerative Medicine (ARM), ... advanced therapies community, today announced the release of ... look at sector trends and metrics from the ... is available online here and also ... here . , Using information provided by ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... seem largely visual the preening, the coy eye contact ... voice may be a means of demonstrating attraction, says Susan ... Pa., in a study, "Vocal and Physiological Changes in Response ... in the fall by the Journal of Nonverbal Behavior ...
... ... play weather, the National Recreation and Park Association (NRPA) is reminding Americans to take the ... To assist, NRPA has published The Dirty Dozen, a comprehensive brochure and playground-safety resource ... ...
... ... Patient Satisfaction Conference June 4th 2010. Expert speakers will discuss improving communications between caregivers, ... , ... 2010 -- Scan Am Company of Algonquin, Illinois, will be hosting a Patient Safety ...
... and when they were readmitted , THURSDAY, May 20 ... disease who decide to discharge themselves before their doctors ... and when they are readmitted. , The finding, set ... for Pharmacoeconomics and Outcomes Research meeting in Atlanta, comes ...
... Gastroesophageal reflux (GER), defined as passage of gastric contents ... in healthy infants, children and adults. When GER causes ... gastroesophageal reflux disease (GERD). During infancy, GER is common ... non-specific symptoms as irritability and cough. Association of non-specific ...
... a study published today in the journal Addiction , ... effective among people with severe mental illnesses as it is ... offering such treatments does not appear to cause deterioration in ... severe mental illnesses (SMI) such as schizophrenia have some of ...
Cached Medicine News:Health News:The sound of seduction 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 3Health News:Patient Safety and Satisfaction are Key Issues at Scan Am Company June Conference 2Health News:When Heart Patients Discharge Themselves, Hospital Bills Increase 2Health News:Disagreement on symptom-reflux association analysis parameters in infants 2Health News:Smoking cessation treatments work and are safe for people with severe mental illness 2
(Date:5/6/2015)... PARIS , May 6, 2015 ... the development and manufacture of filtration products, mainly for ... ZenPure designs custom filters manufactured in a state-of-the-art plant ... are marketed and sold across the globe and will ... Plastics business. This acquisition is fully in ...
(Date:5/6/2015)... , May 6, 2015  Membership in Medicare Supplement ... a Healthcare Business Strategy report released by Mark ... as Medigap or Med Supp plans, covered approximately ... a 5.2% increase from 2013. Between 2013 and ... 551,135 covered lives.  Though UnitedHealth was the segment ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7qn2gf/global_insulin ... "Global Insulin Patch Market Opportunity Analysis" report ... like ultrasound and iontophoresis are being used for ... the type of technique, their prices may vary ... patients. In long-term, it would be considered as ...
Breaking Medicine Technology:Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Global Insulin Patch Market Opportunity Analysis 2015 2
... First Effective Drug for Rare Genetic Disorder in,Children--, ... drug to achieve normal levels of blood sugar ... levels. If this approach,succeeds in humans, it could ... a rare but potentially devastating genetic,disease in which ...
... Pathwork Diagnostics, Gene Expression Test Is the First to Receive FDA, ... ... U.S. Cancer Cases Annually, SUNNYVALE, Calif., July 31 Pathwork ... U.S. Food and Drug Administration (FDA) has cleared its Pathwork(R),Tissue of ...
Cached Medicine Technology:Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 2FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 3FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 4